Eli Lilly Shares Hit All-Time High After FDA Approves Drug for Weight-Loss Treatment
- Investing News
admin
- 0
- 1 minute read
Eli Lilly shares hit an all-time high after receiving FDA approval for Zepbound, an injectable treatment to help people lose weight.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1098111742-222717c9290b4397b3181eb538f1d40f-7552bdce1ac74e3496f26c4dd3e26475.jpg "Canada vs. U.S.: A Side-by-Side Guide to Retirement")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1474708560-6c55d2b4d2b44978aa809c330165c3e5.jpg "Do I Need to File an Income Tax Return Every Year?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-89739213-33fa62bb8fd14c5b98e1ae20e7c0b58b.jpg "3 Surprising Stocks That Have Outperformed Big Names in the Last 10 Years")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1632178785-2bbf98c928b749329959617a646e8bf8.jpg "How WhatsApp Makes Money")